RETRACTED: LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway

Chao Fu, Dongyuan Li, Xiaonan Zhang, Naijie Liu, Guonan Chi, Xingyi JinNeurotherapeutics 2018 · DOI · OpenAlex

Abstract

The current research was aimed at probing into the role of long noncoding RNA (lncRNA) PVT1 in the pathogenesis of glioma and the regulatory mechanism of PVT1/miR-128-3p/GREM1 network in glioma via regulation of the bone morphogenetic protein (BMP) signaling pathway. Microarray analysis was used for preliminary screening for candidate lncRNAs and mRNAs in glioma tissues. Real-time quantitative polymerase chain reaction, Western blot, MTT assay, flow cytometry, migration and invasion assays, and xenograft tumor model were utilized to examine the influence of the lncRNA PVT1/miR-128-3p/GREM1 network on the biological functions of glioma cells. Luciferase assay and RNA-binding protein immunoprecipitation assay were used to validate the miR-128-3p-target relationships with lncRNA PVT1 or GREM1. In addition, the impact of GREM1 on BMP signaling pathway downstream proteins BMP2 and BMP4 was detected via Western blot. LncRNA PVT1 was highly expressed in human glioma tissues and significantly associated with WHO grade (I-II vs III-IV; p < 0.05). There existed a regulatory relationship between lncRNA PVT1 and miR-128-3p as well as that between miR-128-3p and GREM1. MiR-128-3p was downregulated, whereas GREM1 was upregulated in glioma tissues in comparison with para-carcinoma tissues. Overexpression of GREM1 promoted the proliferation and metastatic potential of glioma cells, whereas miR-128-3p mimics inhibited the glioma cell activity through targeting GREM1. Furthermore, lncRNA PVT1 acted as a sponge of miR-128-3p and, thus, influenced the BMP signaling pathway downstream proteins BMP2 and BMP4 through regulating GREM1. LncRNA PVT1 modulated GREM1 and BMP downstream signaling proteins through sponging miR-128-3p, thereby promoting tumorigenesis and progression of glioma.

TL;DR

The long non-coding RNA (lncRNA) PVT1 acts as a molecular "sponge" for the tumor-suppressive microRNA miR-128-3p. This sequestration prevents miR-128-3p from silencing the GREM1 gene, leading to GREM1 overexpression, activation of the BMP signaling pathway, and accelerated glioma progression.

Note: This paper has been retracted. The following summary describes the findings as reported in the original publication.

What Problem Does This Paper Address?

Gliomas are the most common primary intracranial tumors, characterized by high malignancy and poor survival rates. Despite advances in surgery and radiotherapy, resistance to chemotherapy remains a major hurdle. The authors sought to understand the role of "non-coding" RNAs—specifically lncRNAs and microRNAs—which act as critical regulatory switches. By mapping the interaction between lncRNA PVT1 and the BMP signaling pathway, the study aims to uncover potential new therapeutic targets.

Key Insights: The ceRNA Hypothesis and Grade-Dependent Expression

The core idea is the Competitive Endogenous RNA (ceRNA) hypothesis: PVT1 competes with GREM1 for miR-128-3p binding. When PVT1 levels are high, they "soak up" the microRNA, leaving GREM1 free to be expressed.

Crucially, PVT1 and GREM1 expression was found to be significantly higher in high-grade gliomas (WHO III–IV) compared to low-grade ones (I–II) and adjacent normal tissues. This suggests their potential as biomarkers for disease severity.

Expression of lncRNAs (including PVT1) and GREM1 across different glioma grades

Validation in Glioma Cell Lines

The researchers confirmed these expression patterns in several glioma cell lines (U87, SHG-44, U251, and H4). Both PVT1 and GREM1 were markedly upregulated compared to normal brain cells, reinforcing their role as oncogenic drivers.

Relative expression of PVT1 and GREM1 in various glioma cell lines

Functional Impact and BMP Pathway Hijacking

Functional assays showed that knocking down PVT1 inhibited proliferation and invasion while promoting apoptosis. Mechanistically, GREM1 is a known antagonist of BMP signaling. The study suggests that by modulating GREM1, PVT1 indirectly controls the levels of downstream signaling proteins BMP2 and BMP4, which are crucial for tumor cell mobility and proliferation.

Limitations and Future Work

The most significant limitation is the paper's retraction, which necessitates caution regarding the reliability of the data. Mechanistically, while the PVT1/miR-128-3p/GREM1 axis is detailed, the full complexity of the BMP signaling pathway and its interaction with other regulatory networks remains to be fully explored in future, verified research.

Summary updated

Abstract

The current research was aimed at probing into the role of long noncoding RNA (lncRNA) PVT1 in the pathogenesis of glioma and the regulatory mechanism of PVT1/miR-128-3p/GREM1 network in glioma via regulation of the bone morphogenetic protein (BMP) signaling pathway. Microarray analysis was used for preliminary screening for candidate lncRNAs and mRNAs in glioma tissues. Real-time quantitative polymerase chain reaction, Western blot, MTT assay, flow cytometry, migration and invasion assays, and xenograft tumor model were utilized to examine the influence of the lncRNA PVT1/miR-128-3p/GREM1 network on the biological functions of glioma cells. Luciferase assay and RNA-binding protein immunoprecipitation assay were used to validate the miR-128-3p-target relationships with lncRNA PVT1 or GREM1. In addition, the impact of GREM1 on BMP signaling pathway downstream proteins BMP2 and BMP4 was detected via Western blot. LncRNA PVT1 was highly expressed in human glioma tissues and significantly associated with WHO grade (I-II vs III-IV; p < 0.05). There existed a regulatory relationship between lncRNA PVT1 and miR-128-3p as well as that between miR-128-3p and GREM1. MiR-128-3p was downregulated, whereas GREM1 was upregulated in glioma tissues in comparison with para-carcinoma tissues. Overexpression of GREM1 promoted the proliferation and metastatic potential of glioma cells, whereas miR-128-3p mimics inhibited the glioma cell activity through targeting GREM1. Furthermore, lncRNA PVT1 acted as a sponge of miR-128-3p and, thus, influenced the BMP signaling pathway downstream proteins BMP2 and BMP4 through regulating GREM1. LncRNA PVT1 modulated GREM1 and BMP downstream signaling proteins through sponging miR-128-3p, thereby promoting tumorigenesis and progression of glioma.
BibTeX
@inproceedings{fu2018retracted,
  author = {Chao Fu and Dongyuan Li and Xiaonan Zhang and Naijie Liu and Guonan Chi and Xingyi Jin},
  title = {{RETRACTED: LncRNA PVT1 Facilitates Tumorigenesis and Progression of Glioma via Regulation of MiR-128-3p/GREM1 Axis and BMP Signaling Pathway}},
  booktitle = {Neurotherapeutics},
  year = {2018},
  doi = {10.1007/s13311-018-0649-9},
}
Figure